Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members
View by type:
Documents (9899)
Showing 12 of 9899
View All
Showing 727 of 825 pages
10 Presentation from CSOs on their activities in GAVI eligible countries no paper pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 06
11 -12 June 2013
Subject : Presentation from CSOs on their activities in GAVI -eligible
countries
Agenda item : 10
No paper
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 06
11 -12 June 2013
Subject : Presentation from CSOs on their activities in GAVI -eligible
countries
Agenda item : 10
No paper
11 Country Programmes update including Health and immunisation systems strengthening pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 11
11 -12 June 2013
Subject : Country Programmes Update (including Health and
immunisation systems strengthening)
Report of: Hind Khatib -Othman, Managing Director, Country Programmes
Authored by 1: Stefano Malvolti, Director, Vaccine Implementation, and Alan
Brooks , Special Adviser for Immunisation
Agenda item : 11
Category: For Information
Strategic goal : SG1 - Vaccines, SG2 - Health systems, SG3 - Financing
Section A Overview
1 Purpose of the report
1.1 This report provides an update on GAVI?s country p rogrammes .
2 Recommendations
2.1 This report is for information .
3 Executive Summary
3.1 The fourth quarter of 2012 and first five months of 2013 have been periods
of rapid transition and intense work for GAVI?s country programmes. New
or updated collaboration mechanisms for support ing countries (e.g. a
Strategic Goal 2 Management Team) have been rolled out to facilitate
alignment across partners and implementation of the Business Plan. The
Secretariat has increa sed its focus on active programme and grant
management, including strengthening co -ordination between
Transparency and Accountability Policy -related activities and C ountry
Responsible Officer (C RO ) grant management . A new Partnership
Framework Agreement is being implemented that sets out the legal
relationship between GAVI and countries and will speed formalisation of
GAVI funding decisions.
3.2 DR Congo, India, Nigeria and Pakistan continue to require intensive
engagement because of the complex operating en vironments, the large
numbers of unimmunised children and the number of vaccine
implementation activities. The Secretariat has begun to implement the
1 With contributions from Paul Kelly and Bakhuti Shengelia
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 11
11 -12 June 2013
Subject : Country Programmes Update (including Health and
immunisation systems strengthening)
Report of: Hind Khatib -Othman, Managing Director, Country Programmes
Authored by 1: Stefano Malvolti, Director, Vaccine Implementation, and Alan
Brooks , Special Adviser for Immunisation
Agenda item : 11
Category: For Information
Strategic goal : SG1 - Vaccines, SG2 - Health systems, SG3 - Financing
Section A Overview
1 Purpose of the report
1.1 This report provides an update on GAVI?s country p rogrammes .
2 Recommendations
2.1 This report is for information .
3 Executive Summary
3.1 The fourth quarter of 2012 and first five months of 2013 have been periods
of rapid transition and intense work for GAVI?s country programmes. New
or updated collaboration mechanisms for support ing countries (e.g. a
Strategic Goal 2 Management Team) have been rolled out to facilitate
alignment across partners and implementation of the Business Plan. The
Secretariat has increa sed its focus on active programme and grant
management, including strengthening co -ordination between
Transparency and Accountability Policy -related activities and C ountry
Responsible Officer (C RO ) grant management . A new Partnership
Framework Agreement is being implemented that sets out the legal
relationship between GAVI and countries and will speed formalisation of
GAVI funding decisions.
3.2 DR Congo, India, Nigeria and Pakistan continue to require intensive
engagement because of the complex operating en vironments, the large
numbers of unimmunised children and the number of vaccine
implementation activities. The Secretariat has begun to implement the
1 With contributions from Paul Kelly and Bakhuti Shengelia
13 Mid term review and fundraising update document pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 13
11 -12 June 2013
Subject : Mid -term review and fundraising update
Report of: Marie -Ange Saraka -Yao, Director, Resource Mobilisation
Authored by: Marie -Ange Saraka -Yao
Agenda item : 13
Category: For Information
Strategic goal : SG3 - Financing: global predictability/nat'l sustainability
Section A Overview
1 Purpose of the report
1.1 This report present s an update on the s tatus of GAVI?s fundraising efforts
to close the current cycle and transition to the next one , and sets out
preparations for the Mid -Term Review (MTR) , which will take place in
October 2013 .
2 Recommendations
2.1 This report is for information only.
3 Executive summary
3.1 Two years after the 2011 Pledging Conference, strong country demand
and implementation have boost ed programme expenditure , which is now
foreseen to reach US$ 7.8 1 billion for the period 2011 -2015 . In spite of a
challenging fiscal climate in many donor markets and thanks to the
powerful collaborative resource mobilisation effor ts from donors, countries
and vaccine manufacturers , investments in health and immunisation
continue to be a priority among many donors ? including new donors .
3.2 Of the US$ 7. 4 billion resources assured for 2011 -2015, US$ 6. 6 billion
ha s been secured through signed legal agreements , the majority (78%) of
which are multi -year . In the past two years, the payment of pledges has
enabled GAVI to cover 100% of planned expenditures . Such payment has
been accompanied by steady co -financing commit ments from 63
countries , which account for 8% of the vaccine support to those countries.
Similarly, active market shaping efforts are bearing fruit with a substantial
31% reduction in the average price to fully immunise a child with
1 This estimate includes forecasted expenditures for currently approved GAVI interventions and does not
cover any potential future IPV and VIS expenditures. See Doc 05 on Financial forecast .
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 13
11 -12 June 2013
Subject : Mid -term review and fundraising update
Report of: Marie -Ange Saraka -Yao, Director, Resource Mobilisation
Authored by: Marie -Ange Saraka -Yao
Agenda item : 13
Category: For Information
Strategic goal : SG3 - Financing: global predictability/nat'l sustainability
Section A Overview
1 Purpose of the report
1.1 This report present s an update on the s tatus of GAVI?s fundraising efforts
to close the current cycle and transition to the next one , and sets out
preparations for the Mid -Term Review (MTR) , which will take place in
October 2013 .
2 Recommendations
2.1 This report is for information only.
3 Executive summary
3.1 Two years after the 2011 Pledging Conference, strong country demand
and implementation have boost ed programme expenditure , which is now
foreseen to reach US$ 7.8 1 billion for the period 2011 -2015 . In spite of a
challenging fiscal climate in many donor markets and thanks to the
powerful collaborative resource mobilisation effor ts from donors, countries
and vaccine manufacturers , investments in health and immunisation
continue to be a priority among many donors ? including new donors .
3.2 Of the US$ 7. 4 billion resources assured for 2011 -2015, US$ 6. 6 billion
ha s been secured through signed legal agreements , the majority (78%) of
which are multi -year . In the past two years, the payment of pledges has
enabled GAVI to cover 100% of planned expenditures . Such payment has
been accompanied by steady co -financing commit ments from 63
countries , which account for 8% of the vaccine support to those countries.
Similarly, active market shaping efforts are bearing fruit with a substantial
31% reduction in the average price to fully immunise a child with
1 This estimate includes forecasted expenditures for currently approved GAVI interventions and does not
cover any potential future IPV and VIS expenditures. See Doc 05 on Financial forecast .
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 14
11 -12 June 2013
Subject : IFFIm Report
Agenda item : 14
No paper
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 14
11 -12 June 2013
Subject : IFFIm Report
Agenda item : 14
No paper
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 15
11 -12 June 2013
Subject : Risk Management Update
Report of: Helen Evans, Deputy CEO
Authored by: Ciara Goldstein , Analyst, Performance Management and
Adrien de Chaisemartin , Head of Performance Management
Agenda item : 15
Category: For Guidance
Strategic goal : Affects all strategic goals
Section A Overview
1 Purpose of the report
1.1 This report is part of the regular reporting to the Board and the Executive
Committee on the risks faced by the GAVI Alliance in fulfilling its mission.
This risk report is based on the regular risk assessment conducted at the
end of the first quarter 2013 , and made available to the Board on myGAVI
in May 2013 .
1.2 As requested by the Board, key risks identified by the new proposal and
monitoring Independent Review Committees (IRCs) have also been
integrated into this report.
2 Recommendations
2.1 The Board is requested to give guidance on the key risks and mitigation
strategies put in place as well as identify additional risks, as appropriate.
3 Executive summary
3.1 Of note, the Internal Auditor is currently conducting an audit of the risk
management process, which he expects to complete before the November
2013 Board meeting . His findings could result in changes to how the
process is conducted and reported to the Board.
3.2 As of the end of the first quarter 2013, the following items were identified
as the highest risks for the Alliance as part of the risk review process.
(a) Low data quality on immunisation coverage, leading to ineffective
decision making by the GAVI Alliance: The Secretariat convened a
Data Summit in Q1 2013 to review current efforts of t he GAVI Alliance
and partner agencie s working in the area of immunis ation coverage
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 15
11 -12 June 2013
Subject : Risk Management Update
Report of: Helen Evans, Deputy CEO
Authored by: Ciara Goldstein , Analyst, Performance Management and
Adrien de Chaisemartin , Head of Performance Management
Agenda item : 15
Category: For Guidance
Strategic goal : Affects all strategic goals
Section A Overview
1 Purpose of the report
1.1 This report is part of the regular reporting to the Board and the Executive
Committee on the risks faced by the GAVI Alliance in fulfilling its mission.
This risk report is based on the regular risk assessment conducted at the
end of the first quarter 2013 , and made available to the Board on myGAVI
in May 2013 .
1.2 As requested by the Board, key risks identified by the new proposal and
monitoring Independent Review Committees (IRCs) have also been
integrated into this report.
2 Recommendations
2.1 The Board is requested to give guidance on the key risks and mitigation
strategies put in place as well as identify additional risks, as appropriate.
3 Executive summary
3.1 Of note, the Internal Auditor is currently conducting an audit of the risk
management process, which he expects to complete before the November
2013 Board meeting . His findings could result in changes to how the
process is conducted and reported to the Board.
3.2 As of the end of the first quarter 2013, the following items were identified
as the highest risks for the Alliance as part of the risk review process.
(a) Low data quality on immunisation coverage, leading to ineffective
decision making by the GAVI Alliance: The Secretariat convened a
Data Summit in Q1 2013 to review current efforts of t he GAVI Alliance
and partner agencie s working in the area of immunis ation coverage
16 Report of the internal auditor pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 16
11 -12 June 2013
Subject : Report of the Internal Auditor
Report of: Simon Lamb, Managing Director of Internal Audit
Authored by: Simon Lamb
Agenda item : 16
Category: For Information
Strategic goal : Affects all strategic goals
Section A Overview
1 Purpose of the report
1.1 The purpose of this paper is t o inform the Board on Internal Audit?s
activities year -to -date, and those planned for the remainder of the year.
2 Recommendations
2.1 Th is report is for information only .
3 Executive summary
3.1 Th is report describes Internal Audit?s activities in 2013 , past and planned .
3.2 The re is a significant focus on the further development of the Internal Audit
Function . T he paper outlines the plans to establish the key audit
processes which should be in place, consistent with best practice , and
appropriate to support an external Quality Assurance R eview of Internal
Audit ( to be undertaken towards the end of 2014 ). The introduction of
these processes will strengthen the instit ution of Internal Audit in GAVI,
and provide a basis by which the Audit and Finance Committee, on the
Board ?s behalf, can most readily overs ee the function .
3.3 A summary is included of Internal A udit ?s activities year -to -date, and those
planned to be undertak en for the remainder of the year.
3.4 A summary is included of the activities of the Transparency and
Accountability Policy Team (TAP) year -to -date, and those planned to be
undertaken for the remainder of the year.
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 16
11 -12 June 2013
Subject : Report of the Internal Auditor
Report of: Simon Lamb, Managing Director of Internal Audit
Authored by: Simon Lamb
Agenda item : 16
Category: For Information
Strategic goal : Affects all strategic goals
Section A Overview
1 Purpose of the report
1.1 The purpose of this paper is t o inform the Board on Internal Audit?s
activities year -to -date, and those planned for the remainder of the year.
2 Recommendations
2.1 Th is report is for information only .
3 Executive summary
3.1 Th is report describes Internal Audit?s activities in 2013 , past and planned .
3.2 The re is a significant focus on the further development of the Internal Audit
Function . T he paper outlines the plans to establish the key audit
processes which should be in place, consistent with best practice , and
appropriate to support an external Quality Assurance R eview of Internal
Audit ( to be undertaken towards the end of 2014 ). The introduction of
these processes will strengthen the instit ution of Internal Audit in GAVI,
and provide a basis by which the Audit and Finance Committee, on the
Board ?s behalf, can most readily overs ee the function .
3.3 A summary is included of Internal A udit ?s activities year -to -date, and those
planned to be undertak en for the remainder of the year.
3.4 A summary is included of the activities of the Transparency and
Accountability Policy Team (TAP) year -to -date, and those planned to be
undertaken for the remainder of the year.
17 Review of decisions and actions no paper pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 17
11 -12 June 2013
Subject : Review of decisions and actions
Agenda item : 17
No paper
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 17
11 -12 June 2013
Subject : Review of decisions and actions
Agenda item : 17
No paper
18 Closing remarks and any other business no paper pdf
1
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 18
11 -12 June 2013
Subject : Closing remarks and any other business
Agenda item : 18
No paper
Report to the
GAVI Alliance Board
Board -2013 -Mtg -1-Doc 18
11 -12 June 2013
Subject : Closing remarks and any other business
Agenda item : 18
No paper
Annex Committee minutes 11 12 June 2013 pdf
Board -2013 -Mtg -1-Annex: Committee minutes
GAVI Alliance Board Meeting
11 -12 June 2013
Starling Hotel, Geneva, Switzerland
Monday 10 June: Pre -Board meetings
Tuesday 11 June: 0 8.30 -18.15 (Board meeting Day One)
Wednesday 12 June: 0 8.30 -17.30 (Board meeting Day Two)
Annex: Committee minutes
Annex Pages MINUTES
1-5 - Executive Committee ? 15 February 2013
6-14 - Executive Committee ? 20 -22 March 2013 (Decision slides)
15 -17 - Executive Committee ? 1 May 201 3 (Decision slides)
18 -22 - Audit and Finance Committee ? 5 February 2013
23 -27 - Audit and Finance Committee ? 22 April 2013 (Decision slides)
28 -33 - Programme and Policy Cte ? 29 -30 April 2013 (Decision slides)
34 -39 - Governance Committee ? 20 -22 March 2013
40 -49 - Governance Committee ? 7 May 2013 (Decision slides)
50 -53 - Investment Committee ? 19 February 2013
54 -56 - Investment Committee ? 26 April 2013 (Decision slides)
Note: Minutes of committee meetings held since the Dar es Salaam Board meeting
are included in this annex for ease of reference. Decision slides are included instead
of meeting minutes that are not yet approved.
GAVI Alliance Board Meeting
11 -12 June 2013
Starling Hotel, Geneva, Switzerland
Monday 10 June: Pre -Board meetings
Tuesday 11 June: 0 8.30 -18.15 (Board meeting Day One)
Wednesday 12 June: 0 8.30 -17.30 (Board meeting Day Two)
Annex: Committee minutes
Annex Pages MINUTES
1-5 - Executive Committee ? 15 February 2013
6-14 - Executive Committee ? 20 -22 March 2013 (Decision slides)
15 -17 - Executive Committee ? 1 May 201 3 (Decision slides)
18 -22 - Audit and Finance Committee ? 5 February 2013
23 -27 - Audit and Finance Committee ? 22 April 2013 (Decision slides)
28 -33 - Programme and Policy Cte ? 29 -30 April 2013 (Decision slides)
34 -39 - Governance Committee ? 20 -22 March 2013
40 -49 - Governance Committee ? 7 May 2013 (Decision slides)
50 -53 - Investment Committee ? 19 February 2013
54 -56 - Investment Committee ? 26 April 2013 (Decision slides)
Note: Minutes of committee meetings held since the Dar es Salaam Board meeting
are included in this annex for ease of reference. Decision slides are included instead
of meeting minutes that are not yet approved.
GAVI Alliance Board Minutes 11 12 June 2013 pdf
GAVI Alliance Board Meeting
11 -12 June 2013
Board -2013 -Mtg -1 1
GAVI Alliance Board Meeting
11 -12 June 201 3
Geneva , Switzerland
FINAL M INUTES
1. Chair?s report
1.1 Finding a quorum of members present, the meeting commenced at 08.30
local time on 11 June 201 3. Dagfinn H?ybr?ten , Board Chair , chaired the
meeting.
1.2 The Chair welcomed the Board members to Geneva and extended a special
welcome to several new Board members and alternate Board members
attending a Board meeting for the first time. He also welcomed Ren ? Karsent i
and his colleagues from the IFFIm Board.
1.3 On behalf of the Board he extended congratulations to Olga Popova who had
recently given birth to GAVI?s fir st Board baby, and wished a speedy recovery
to Paul Fife who had recently suffered a stroke.
1.4 The Chair reminded the Board that Nelson Mandela had been the first Chair
of the GAVI Vaccine Fund Board, one of the organisations founding fathers
who had brough t some key donors to GAVI and who continues to be an
inspiration to all. He would be sending, also on behalf of the Board, greetings
from this meeting and wishes for a speedy recovery.
1.5 The Chair n oted that a number of departing Board members would be
recog nised at the dinner that evening but extended a special word of thanks
to Gustavo Gonzalez -Can ali, who had rece ntly informed the Chair and the
Vice Chair of his intention to step down as PPC Chair as his current role at the
French Ministry of Foreign Affairs would end in August. The Chair expressed,
also on behalf of the Board, his appreciation for Dr Gonzalez -Can ali?s
dedication to GAVI over the years and his leadership of the PPC, a role which
wa s no doubt challenging but one which he had fulfilled w ith great success.
1.6 Standing declarations of interest were tabled to the Board (Doc 01a in the
Board pa ck). Alan Hinman declared grants received from the Bill & Melinda
Gates Foundation (BMGF) for cholera and inactivated polio vaccine, and
Zulfiqar Bhutta declared a grant received, also from BMGF, to support polio
eradication in Pakistan.
Seth Berkley, MD
Chief Executive Officer
CEO Board Report
GAVI Alliance Board meeting
Geneva, Switzerland
11 -12 June 2013
GAVI Alliance Board meeting
11 -12 June 2013
Overview of presentation
? R esults
? Accelerated vaccine support
? Hot topics
? Expenditure and resources ? horizon view
? Opportunities and challenges
? Board agenda: key decisions and discussions
Chief Executive Officer
CEO Board Report
GAVI Alliance Board meeting
Geneva, Switzerland
11 -12 June 2013
GAVI Alliance Board meeting
11 -12 June 2013
Overview of presentation
? R esults
? Accelerated vaccine support
? Hot topics
? Expenditure and resources ? horizon view
? Opportunities and challenges
? Board agenda: key decisions and discussions